CP, as the main and crucial metabolite generated from ENR biotransformation, also had antibacterial activity for the treatment of bacterial infections (Aydemir et al., 2006; Hickerson and Carson, 2006; San et al., 2007; Schilt, 2012). Here, CP is linked to bacterial infectious disease.